SCHEMBL22739740

SCHEMBL22739740

CCc1ccc(C(=O)CCCC(=O)c2ccc(CC)s2)s1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 6/20 0.51
ALDH1A1 P00352 5/20 0.51
POLB P06746 2/20 0.51
TDP1 Q9NUW8 1/20 0.51
RAB9A P51151 6/20 0.46
NPC1 O15118 5/20 0.46
SMN1; SMN2 Q16637 5/20 0.46
TSHR P16473 3/20 0.46
TP53 P04637 2/20 0.46
SMYD3 Q9H7B4 1/20 0.44
KMT2A Q03164 2/20 0.43
HTT P42858 3/20 0.42
LMNA P02545 3/20 0.42
MAPT P10636 2/20 0.42
PRNP P04156 1/20 0.42
RECQL P46063 1/20 0.42
RXFP1 Q9HBX9 1/20 0.42
MEN1 O00255 1/20 0.41
KDM4E B2RXH2 1/20 0.40
NFKB1 P19838 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15979674 0.92 ALDH1A1 (0.54) HPGDALDH1A1POLBTDP1RAB9A
SCHEMBL23222294 0.89 HPGD (0.51) HPGDALDH1A1POLBTDP1RAB9A
SCHEMBL4262198 0.85 POLB (0.56) HPGDALDH1A1POLBTDP1RAB9A
SCHEMBL13078179 0.84 POLB (0.58) HPGDALDH1A1POLBTDP1RAB9A
SCHEMBL10250399 0.82 ALDH1A1 (0.53) HPGDALDH1A1POLBTDP1RAB9A
SCHEMBL2245062 0.81 GSK3B (0.58) HPGDALDH1A1POLBTDP1RAB9A
SCHEMBL3930128 0.81 RAB9A (0.63) HPGDALDH1A1POLBTDP1RAB9A
SCHEMBL2244978 0.81 ALDH1A1 (0.51) HPGDALDH1A1POLBTDP1RAB9A
SCHEMBL15979709 0.80 ALDH1A1 (0.66) HPGDALDH1A1POLBRAB9ANPC1
SCHEMBL27981316 0.79 HPGD (0.58) HPGDALDH1A1POLBTDP1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220135549-A1 BISPYRANILIDENES, DITHIOBISPYRANILIDENES AND DISELENOBISPYRANILIDENE AND USE THEREOF SENORICS GMBH (DE) 2022-05-05 US disclosed
WO-2020239456-A1 BISPYRANILIDENES, DITHIOBISPYRANILIDENES AND DISELENOBISPYRANILIDENE AND USE THEREOF SENORICS GMBH (DE) 2020-12-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220135549-A1 BISPYRANILIDENES, DITHIOBISPYRANILIDENES AND DISELENOBISPYRANILIDENE AND USE THEREOF PIN1, QDPR, DHPS HPGD 620/4885ALDH1A1 158/4885POLB 2346/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.